icone plus
Contact
Abonnez-vous aux actualités
Continuité d'Autorisation d’accès précoce octroyée à la spécialité SCEMBLIX (asciminib).
Voir aussi
Décision d'accès précoce
22/04/2022
Décision d'accès précoce
01/12/2022
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
ZqJXJqgXc48AK0FL